# A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir

> **NCT07552779** · PHASE1 · RECRUITING · sponsor: **Pfizer** · enrollment: 18 (estimated)

## Conditions studied

- Coronavirus Disease 2019
- Coronavirus Disease 2019 (COVID-19)
- COVID-19 (Coronavirus Disease 2019)
- Upper Respiratory Tract Infections
- Respiratory Tract Infection
- Respiratory Tract Diseases
- COVID-19
- COVID-19 Infection
- COVID-19 SARS-CoV-2 Infection
- Pneumonia
- Lung Diseases

## Interventions

- **DRUG:** Ibuzatrelvir co-process API film coated tablet
- **DRUG:** Ibuzatrelvir filmcoated tablet

## Key facts

- **NCT ID:** NCT07552779
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-13
- **Primary completion:** 2026-06-03
- **Final completion:** 2026-07-06
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07552779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07552779, "A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07552779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*